Editorials
Late outcomes of congenital heart disease
Translational Pediatrics
2013;
2
(3)
:84-86
.
(26 July 2013)
Shall we treat congenital heart lesions, their suffering patients or also their families, and surrounding societal ambience?
Translational Pediatrics
2013;
2
(3)
:87-89
.
(26 July 2013)
Original Article
Long term psychosocial outcomes of congenital heart disease (CHD) in adolescents and young adults
Translational Pediatrics
2013;
2
(3)
:90-98
.
(26 July 2013)
Review Articles
Vitamin D deficiency in surgical congenital heart disease: prevalence and relevance
Translational Pediatrics
2013;
2
(3)
:99-111
.
(26 July 2013)
The concept and practice of Fanconi Anemia: from the clinical bedside to the laboratory bench
Translational Pediatrics
2013;
2
(3)
:112-119
.
(26 July 2013)
Hodgkin Lymphoma1
Pediatric Hodgkin Lymphoma: on the road to a ‘radiotherapy-free’ cure rate?—Commentary on a report on final results of the Multinational Trial GPOH-HD95
Translational Pediatrics
2013;
2
(3)
:120-123
.
(26 July 2013)
Treatment of children and adolescents with Hodgkin’s Lymphoma without radiotherapy for patients in complete remission after chemotherapy
Translational Pediatrics
2013;
2
(3)
:124-125
.
(26 July 2013)
Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma
Translational Pediatrics
2013;
2
(3)
:126-130
.
(26 July 2013)
Treatment of Hodgkin’s lymphoma in childhood and adolescence without radiotherapy
Translational Pediatrics
2013;
2
(3)
:131-132
.
(26 July 2013)
Meet the Professor2
Professor Fengcai Zhu: China leads the EV-71 vaccine research and development
Translational Pediatrics
2013;
2
(3)
:133-136
.
(26 July 2013)
Disclosure:
1. The series “Hodgkin Lymphoma” was commissioned by the editorial office, Translational Pediatrics without any sponsorship or funding.
2. The series “Meet the Professor” was commissioned by the editorial office, Translational Pediatrics without any sponsorship or funding.
